Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.72
1.11%
After-hours: Aug 15, 2025, 04:31 PM EDT
Cocrystal Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 144K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.43K | n/a | n/a | n/a |
Cost of Revenue | n/a | 28K | n/a | 33K | 35K | 72K | 108K | 101K | 103K | 241.6K | 98K | 95K | 95K | 239.5K | 98K | 95K | 92K |
Gross Profit | n/a | n/a | n/a | -33K | -35K | 72K | -108K | -101K | -103K | -241.6K | -98K | -95K | -95K | -234.07K | -98K | -95K | -92K |
Operating Income | -2.34M | -3.23M | -5.04M | -5.45M | -4.16M | -5.67M | -4.44M | -4.34M | -5.11M | -4.5M | -5.69M | -24.43M | -4.21M | -3.7M | -3.95M | -3.83M | -2.74M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 180K | 320K | 140K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.3M | -3.27M | -4.94M | -5.34M | -3.96M | -4.46M | -4.17M | -4.17M | -5.19M | -4.5M | -5.7M | -24.43M | -4.21M | -3.69M | -3.94M | -3.82M | -2.74M |
Net Income | -2.3M | -3.27M | -4.94M | -5.34M | -3.96M | -4.46M | -4.17M | -4.17M | -5.27M | -4.5M | -5.71M | -45.12M | -4.21M | -3.69M | -3.94M | -3.82M | -2.74M |
Selling & General & Admin | 981K | 1.19M | 1.8M | 1.14M | 1.17M | 1.4M | 1.85M | 1.54M | 1.2M | 1.22M | 1.82M | 1.38M | 1.33M | 1.4M | 1.79M | 1.08M | 1.16M |
Research & Development | 1.36M | 2.04M | 3.24M | 4.31M | 2.95M | 4.27M | 4.19M | 2.8M | 3.91M | 3.29M | 3.87M | 2.36M | 2.87M | 2.31M | 2.17M | 2.75M | 1.58M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.69M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.34M | 3.2M | 5.04M | 5.45M | 4.12M | 5.67M | 6.04M | 4.34M | 5.11M | 4.5M | 5.69M | 3.74M | 4.21M | 3.7M | 3.95M | 3.83M | 2.74M |
Interest Expense | 37K | n/a | n/a | n/a | 220K | n/a | 320K | 140K | 78K | 1K | 1K | n/a | 1K | n/a | 1K | 2K | 1K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 3.33M | 5.04M | 5.45M | 4.16M | 5.67M | 6.04M | 4.34M | 5.11M | 4.5M | 5.69M | 3.74M | 4.21M | 3.7M | 3.95M | 3.83M | 2.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -30.48K | n/a | n/a | 78K | 2K | 6K | 20.69M | 3K | -6 | 1K | 2K | 1K |
Shares Outstanding (Basic) | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.15M | 10.06M | 8.14M | 8.14M | 8.14M | 8.12M | 8.12M | 7.26M | 8.12M | 7.26M | 5.94M |
Shares Outstanding (Diluted) | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.15M | 10.06M | 8.14M | 8.14M | 8.14M | 8.12M | 8.12M | 7.26M | 8.14M | 7.26M | 5.94M |
EPS (Basic) | -0.23 | -0.32 | -0.49 | -0.53 | -0.39 | -0.44 | -0.41 | -0.41 | -0.65 | -0.55 | -0.7 | -5.55 | -0.52 | -0.51 | -0.49 | -0.53 | -0.46 |
EPS (Diluted) | -0.23 | -0.32 | -0.49 | -0.53 | -0.39 | -0.44 | -0.41 | -0.41 | -0.65 | -0.55 | -0.7 | -5.55 | -0.52 | -0.51 | -0.48 | -0.53 | -0.46 |
EBITDA | -2.34M | -3.13M | -4.94M | -5.42M | -4.12M | -4.46M | -5.99M | -4.34M | -5.06M | -4.4M | -5.6M | -3.69M | -4.11M | -3.59M | -3.84M | -3.72M | -2.69M |
EBIT | n/a | -3.27M | -5.04M | -5.45M | -4.16M | -5.67M | -6.04M | -4.34M | -5.11M | -4.5M | -5.69M | -3.74M | -4.21M | -3.69M | -3.94M | -3.82M | -2.74M |
Depreciation & Amortization | n/a | 101K | 99K | 33K | 35K | -1.7M | 108K | 101K | 103K | 100K | 98K | 95K | 95K | 97K | 98K | 95K | 92K |